Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Feb;15(2):251-8.
doi: 10.1111/j.1365-3156.2009.02445.x. Epub 2009 Dec 9.

Mortality after failure of antiretroviral therapy in sub-Saharan Africa

Olivia Keiser  1 , Hannock Tweya, Paula Braitstein, François Dabis, Patrick MacPhail, Andrew Boulle, Denis Nash, Robin Wood, Ruedi Lüthi, Martin W G Brinkhof, Mauro Schechter, Matthias Egger; ART-LINC of IeDEA Study Group
Affiliations
Multicenter Study

Mortality after failure of antiretroviral therapy in sub-Saharan Africa

Olivia Keiser et al. Trop Med Int Health. 2010 Feb.

Abstract

Objective: To assess the outcome of patients who experienced treatment failure with antiretrovirals in sub-Saharan Africa.

Methods: Analysis of 11 antiretroviral therapy (ART) programmes in sub-Saharan Africa. World Health Organization (WHO) criteria were used to define treatment failure. All ART-naive patients aged >or=16 who started with a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen and had at least 6 months of follow-up were eligible. For each patient who switched to a second-line regimen, 10 matched patients who remained on a non-failing first-line regimen were selected. Time was measured from the time of switching, from the corresponding time in matched patients, or from the time of treatment failure in patients who remained on a failing regimen. Mortality was analysed using Kaplan-Meier curves and random-effects Cox models.

Results: Of 16 591 adult patients starting ART, 382 patients (2.3%) switched to a second-line regimen. Another 323 patients (1.9%) did not switch despite developing immunological or virological failure. Cumulative mortality at 1 year was 4.2% (95% CI 2.2-7.8%) in patients who switched to a second-line regimen and 11.7% (7.3%-18.5%) in patients who remained on a failing first-line regimen, compared to 2.2% (1.6-3.0%) in patients on a non-failing first-line regimen (P < 0.0001). Differences in mortality were not explained by nadir CD4 cell count, age or differential loss to follow up.

Conclusions: Many patients who meet criteria for treatment failure do not switch to a second-line regimen and die. There is an urgent need to clarify the reasons why in sub-Saharan Africa many patients remain on failing first-line ART.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selection of study patients. Patients in grey boxes were included in analyses.
Figure 2
Figure 2
Kaplan-Meier curves of mortality in patients who remained on a failing first-line antiretroviral regimen, patients who switched to a second-line regimen and patients who remained on a non-failing first-line regimen.
See this image and copyright information in PMC

References

    1. Bisson GP, Gross R, Strom JB, et al. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS. 2006;20:1613–1619. - PubMed
    1. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–824. - PubMed
    1. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559–567. - PMC - PubMed
    1. Dabis F, Balestre E, Braitstein P, et al. Antiretroviral Therapy in Lower Income Countries (ART-LINC): International collaboration of treatment cohorts. Int J Epidemiol. 2005;34:979–986. - PubMed
    1. Forster M, Bailey C, Brinkhof MW, et al. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ. 2008;86:939–947. - PMC - PubMed

Publication types

Substances